A randomized, double-masked, active-controlled, crossover phase III equivalence study of generic dorzolamide 2% versus innovator Trusopt® eye drop solution in subjects with open-angle glaucoma or ocular hypertension

Bell, KatharinaKorb, ChristinaButsch, ChristinaGiers, Bert ConstantinBeck, AnnaStrzalkowska, AlicjaRuckes, ChristianKlingberg, UlrikePfeiffer, NorbertLorenz, Katrin2023-01-202023-01-202022https://openscience.ub.uni-mainz.de/handle/20.500.12030/8618engCC-BY-4.0https://creativecommons.org/licenses/by/4.0/610 Medizin610 Medical sciencesA randomized, double-masked, active-controlled, crossover phase III equivalence study of generic dorzolamide 2% versus innovator Trusopt® eye drop solution in subjects with open-angle glaucoma or ocular hypertensionZeitschriftenaufsatz